169 related articles for article (PubMed ID: 18469454)
1. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
Saadati H; Saif MW
JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
[No Abstract] [Full Text] [Related]
2. Safety of capecitabine use in patients with liver dysfunction.
Saif MW; Tejani MA
Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
[No Abstract] [Full Text] [Related]
3. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
Aksoy S; Karaca B; Dinçer M; Yalçin S
Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
[No Abstract] [Full Text] [Related]
4. [Therapy traces on hands and feet in a patient with colon cancer].
Stiefelhagen P
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():9. PubMed ID: 22916416
[No Abstract] [Full Text] [Related]
5. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
6. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
Macková D
Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
[TBL] [Abstract][Full Text] [Related]
7. Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
[No Abstract] [Full Text] [Related]
8. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
[No Abstract] [Full Text] [Related]
9. Capecitabine induced colitis.
Maggo G; Grover SC; Grin A
Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
Prescrire Int; 1999 Jun; 8(41):74-5. PubMed ID: 10558444
[TBL] [Abstract][Full Text] [Related]
12. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
13. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Dong NN; Wang MY; Zhang Q; Liu ZF
Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.
Shahrokni A; Rajebi MR; Harold L; Saif MW
JOP; 2009 Mar; 10(2):215-20. PubMed ID: 19287123
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
16. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Saif MW; Black G; Johnson M; Russo S; Diasio R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
[TBL] [Abstract][Full Text] [Related]
17. Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Wilkowski R; Bruns CJ; Issels RD; Schulz C; Moosmann N; Laessig D; Haas M; Golf A; Heinemann V
Oncology; 2007; 73(3-4):221-7. PubMed ID: 18424886
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine-induced cerebellar toxicity.
Renouf D; Gill S
Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
[TBL] [Abstract][Full Text] [Related]
19. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma.
Carstens H; Albertsson M
Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
